Why Should You Put Syros Pharmaceuticals Inc. (NASDAQ: SYRS) On Your Portfolio?
Currently, there are 26.45M common shares owned by the public and among those 19.89M shares have been available to trade. The company’s stock has a 5-day price change of -64.11% and -62.06% over the past three months. SYRS shares are trading -75.35% year to date (YTD), with the 12-month market performance down to -49.74% lower. […]
An Important Check-Up On Syros Pharmaceuticals Inc. (NASDAQ: SYRS)
Avidity Partners Management LP has recently announced that it has increased stake in Syros Pharmaceuticals Inc. (NASDAQ:SYRS) by 8.00%. After grabbing 1.58 million shares, the institutional investor is now in possession of 0.12 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.64% having worth around $3.94 million. […]
